Falsely Elevated Sodium Levels During Thiopental Treatment in the ICU: Technical Interference on a Laboratory Device with Important Clinical Relevance
- 27 October 2012
- journal article
- Published by Springer Nature in Neurocritical Care
- Vol. 18 (1) , 64-69
Abstract
Thiopental is a cornerstone in the treatment of refractory status epilepticus and intractable intracranial hypertension. In our center we observed that thiopental might cause falsely elevated serum sodium levels. Triggered by a recent case experience of extremely elevated serum sodium levels during thiopental treatment, we retrospectively identified 53 patients treated with thiopental in our intensive care unit between 2007 and 2011 and evaluated electrolyte changes. We differentiated the analysis before and after introduction of a new device for sodium assays (Dimension Vista, Siemens) in the central laboratory in April 2010. Standardized in vitro laboratory tests were performed to study the effect of thiopental on sodium analysis. Before April 2010, serum sodium levels determined in the central laboratory showed a good agreement with the bedside point-of-care (POC) device during thiopental therapy with [sodium]laboratory − [sodium]POC of only 1.08 mmol/L (P = .0517). After April 2010, a strong discrepancy between laboratory values and POC values was observed with [sodium]laboratory − [sodium]POC = 11.57 mmol/L (P < .0001). Standardized in vitro testing confirmed that thiopental induced a dose-dependent false hypernatremia (P = .002). Thiopental treatment can result in falsely elevated serum sodium. This is a critical finding since high sodium levels preclude administrating mannitol or hypertonic saline for the treatment of elevated intracranial pressure. Moreover, a false high sodium level might lead to the inappropriate administration of hypotonic fluids potentially resulting in increased brain edema and even higher intracranial pressure. To our knowledge, this is the first paper describing this clinically relevant phenomenon.Keywords
This publication has 10 references indexed in Scilit:
- Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case seriesIntensive Care Medicine, 2011
- Hypokalaemia with Severe Rebound Hyperkalaemia After Therapeutic Barbiturate ComaAnesthesia & Analgesia, 2009
- A Critical Review: Does Thiopental Continuous Infusion Warrant Therapeutic Drug Monitoring in the Critical Care Population?Therapeutic Drug Monitoring, 2009
- Propylene Glycol Toxicity Complicating Use of Barbiturate ComaNeurocritical Care, 2008
- XI. Anesthetics, Analgesics, and SedativesJournal of Neurotrauma, 2007
- The Use of Hypertonic Saline for Treating Intracranial Hypertension After Traumatic Brain InjuryAnesthesia & Analgesia, 2006
- Disturbances of Sodium in Critically Ill Adult Neurologic PatientsJournal of Neurosurgical Anesthesiology, 2006
- Barbiturates for acute neurological and neurosurgical emergencies – do they still have a role?Journal of Clinical Neuroscience, 2003
- Life-threatening hyperkalaemia following therapeutic barbiturate comaIntensive Care Medicine, 2002
- Benzalkonium interference with test methods for potassium and sodiumClinical Chemistry, 1990